Only CCL2 showed a statistically significant chemo-attractant capacity (referred to as the basal migratory capacity, data not shown) over pDCs and cDC2, not just in HCs but also in IBD (Figure 3). The gene discussed is CCL2; the disease is inflammatory bowel disease.